drugset / Trial / NCT02682238
A Safety, Tolerability and Preliminary Efficacy Study of BBI-4000 Gel in Subjects With Palmar Hyperhidrosis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To assess the safety and local tolerability of BBI-4000 15% gel compared with vehicle (placebo) when applied topically once daily in subjects with palmar hyperhidrosis.
Timeline
- Start
- 2016-03-08
- Primary completion
- 2016-07-14
- Completion
- 2016-10-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SOFPIRONIUM | Small molecule | 15 % | Topical |